Free public records show Daewoong Pharmaceutical Co. LTD. in 3 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Daewoong Pharmaceutical Co. LTD. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
28 active studies led by Daewoong Pharmaceutical Co. LTD., of 200 in all
Source: ClinicalTrials.gov, Studies with Daewoong Pharmaceutical Co. LTD. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Studies Daewoong Pharmaceutical Co. LTD. leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Daewoong Pharmaceutical Co. LTD. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Daewoong Pharmaceutical Co. LTD.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Daewoong Pharmaceutical Co. LTD. is in.
Stories on the topics Daewoong Pharmaceutical Co. LTD. works in.
2.6 billion adults are overweight. GLP-1 medicines are changing weight care, while most supplements lack…
Read
Omega-3 supplements are hugely popular. Big trials give mixed answers on whether they protect the heart.
Read
Nearly 15% of US Medicare beneficiaries, 8.2 million people, had a wound or wound infection in one year…
ReadSearch all reports for Daewoong Pharmaceutical Co. LTD. All companies